Lajoinie, Audrey
23  results:
Search for persons X
?
 
?
4

Protocol of GLUcose COntrol Safety and Efficacy in type 2 D..:

Grenet, Guillaume ; Lajoinie, Audrey ; Ribault, Shams...
Fundamental & Clinical Pharmacology.  31 (2017)  3 - p. 258-264 , 2017
 
?
6

Risk of medication error administering ciprofloxacin oral s..:

EREMI Group ; Lajoinie, Audrey ; Valla, Frederic V..
European Journal of Clinical Pharmacology.  71 (2015)  6 - p. 769-770 , 2015
 
?
 
?
8

Solid oral forms availability in children: a cost saving in..:

Lajoinie, Audrey ; Henin, Emilie ; Kassai, Behrouz.
British Journal of Clinical Pharmacology.  78 (2014)  5 - p. 1080-1089 , 2014
 
?
10

Real-life omalizumab exposure and discontinuation in a larg..:

Humbert, Marc ; Bourdin, Arnaud ; Taillé, Camille...
info:eu-repo/semantics/altIdentifier/doi/10.1183/13993003.03130-2021.  , 2022
 
?
12

Real-life omalizumab exposure and discontinuation in a larg..:

Humbert, Marc ; Bourdin, Arnaud ; Taillé, Camille...
info:eu-repo/semantics/altIdentifier/doi/10.1183/13993003.03130-2021.  , 2022
 
?
13

Real-life omalizumab exposure and discontinuation in a larg..:

Humbert, Marc ; Bourdin, Arnaud ; Taillé, Camille...
info:eu-repo/semantics/altIdentifier/doi/10.1183/13993003.03130-2021.  , 2022
 
?
14

Cervical cancer screening coverage, management of squamous ..:

de Rycke, Yann ; Tubach, Florence ; Lafourcade, Alexandre...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0228660.  , 2020
 
?
15

Cervical cancer screening coverage, management of squamous ..:

De Rycke, Yann ; Tubach, Florence ; Lafourcade, Alexandre...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0228660.  , 2020
 
1-15